HK Stock Market Move | Luye Pharma (02186) surged over 6% in early trading as the mRNA vaccine LY01620 is set to begin Phase II clinical trials in China.
Green Leaf Pharmaceutical (02186) rose over 6% in early trading, and as of the time of publication, it has increased by 6.53%, reaching HKD 2.28, with a transaction volume of HKD 42.4818 million.
LUYE PHARMA (02186) rose over 6% in early trading, and as of the time of this report, it is up 6.53%, priced at HKD 2.28, with a transaction volume of HKD 42.4818 million.
On the news front, on August 20, LUYE PHARMA announced that its self-developed messenger RNA (mRNA) vaccine LY01620 is set to begin Phase II clinical trials in China. The study aims to enroll patients with histologically confirmed high-grade squamous intraepithelial lesions (HSIL) positive for human papillomavirus 16 (HPV16), to further assess the efficacy and safety of LY01620.
Compared to traditional surgical treatments, therapeutic vaccines can be applied at various stages of HPV infection, potentially blocking the progression to cervical cancer. The companys management believes that developing a therapeutic HPV vaccine is an urgent clinical need as a highly effective non-surgical immunotherapy option. LY01620 is expected to fill the gap in HPV therapeutic vaccines, providing new treatment options for HPV-related diseases. In addition, the company is actively exploring the clinical application prospects of LY01620 in HPV-related solid tumors, further unlocking the therapeutic value and potential of the product.
Related Articles
HK Stock Market Move | COSCO Shipping Energy Transportation (01138) rose by nearly 5% again, and ship-to-ship transfer and extended voyage will continue to occupy VLCC capacity.
HK Stock Market Move | 5100 XIZANG (01115) rises over 5% as it grants a Malaysian company the distribution rights for the Southeast Asian and Middle Eastern markets, accelerating its overseas market expansion.
HK Stock Market Move | 3SBIO (01530) rose over 7% with an adjusted net profit attributable to shareholders growing 26.5% year-on-year in the first half of the year.
HK Stock Market Move | COSCO Shipping Energy Transportation (01138) rose by nearly 5% again, and ship-to-ship transfer and extended voyage will continue to occupy VLCC capacity.
HK Stock Market Move | 5100 XIZANG (01115) rises over 5% as it grants a Malaysian company the distribution rights for the Southeast Asian and Middle Eastern markets, accelerating its overseas market expansion.
HK Stock Market Move | 3SBIO (01530) rose over 7% with an adjusted net profit attributable to shareholders growing 26.5% year-on-year in the first half of the year.
RECOMMEND
